P&G said it is taking this action because this product does not contain a child-resistant backing for the blister packs in the box, despite label statements that the product is in child-resistant packaging.
No accidental ingestion by children has been reported with this product, and the medication itself is safe for use when taken as directed. However, this product is not intended for use by children under 12, unless recommended by a physician. The lack of child-resistant packaging means it is possible that a child could gain access to the medicine.
Consumers who purchased this DayQuil® 24-count product with the expectation that it was in child-resistant packaging can call P&G at 1-800-251-3374 for a refund or replacement coupon. Anyone with a question can call P&G at this toll-free number or visit www.vicks.com.
Consumers who wish to continue to use the product should do so as directed, taking extra care to keep it out of the reach of children. This medicine could cause serious health problems or death to a child if accidentally swallowed. This product is not intended for children under 12 without a physician’s recommendation.
No other DayQuil® or Vicks® products are affected.
P&G has informed the Consumer Product Safety Commission and U.S. Food and Drug Administration. Both support the company’s action.
